These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1169018)

  • 41. Interaction of lymphocytes with Kupffer cells from halothane-exposed guinea pigs.
    Furst SM; Gandolfi AJ
    Int Arch Allergy Immunol; 1997 Sep; 114(1):46-53. PubMed ID: 9303330
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatotoxicity in guinea pigs following acute inhalation exposure to 1,1-dichloro-2,2,2-trifluoroethane.
    Marit GB; Dodd DE; George ME; Vinegar A
    Toxicol Pathol; 1994; 22(4):404-14. PubMed ID: 7817129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatic necrosis produced by repeated administration of halothane to guinea pigs.
    Hughes HC; Lang CM
    Anesthesiology; 1972 May; 36(5):466-71. PubMed ID: 5021948
    [No Abstract]   [Full Text] [Related]  

  • 44. Altered hepatic calcium homeostasis in guinea pigs with halothane-induced hepatotoxicity.
    Farrell GC; Mahoney J; Bilous M; Frost L
    J Pharmacol Exp Ther; 1988 Nov; 247(2):751-6. PubMed ID: 3183968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Guinea-pig model of halothane-associated hepatotoxicity in the absence of enzyme induction and hypoxia.
    Lunam CA; Cousins MJ; Hall PD
    J Pharmacol Exp Ther; 1985 Mar; 232(3):802-9. PubMed ID: 3973829
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impaired bile flow and disordered hepatic calcium homeostasis are early features of halothane-induced liver injury in guinea pigs.
    Frost L; Mahoney J; Field J; Farrell GC
    Hepatology; 1996 Jan; 23(1):80-6. PubMed ID: 8550053
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Time course of 72-kilodalton heat shock protein induction and appearance of trifluoroacetyl adducts in livers of halothane-exposed rats.
    Lin WQ; van Dyke RA; Marsh HM; Trudell JR
    Mol Pharmacol; 1994 Oct; 46(4):639-43. PubMed ID: 7526150
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Halothane and hepatitis. Incidence, predisposing factors and exposure guidelines.
    Neuberger JM
    Drug Saf; 1990; 5(1):28-38. PubMed ID: 2178633
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative toxicities of halothane, isoflurane, and diethyl ether at subanesthetic concentrations in laboratory animals.
    Stevens WC; Eger EI; White A; Halsey MJ; Munger W; Gibbons RD; Dolan W; Shargel R
    Anesthesiology; 1975 Apr; 42(4):408-19. PubMed ID: 1119708
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suppressive effect of vitamin E on lipid peroxidation in halothane-administered guinea pig liver.
    Sato N; Fujii K; Yuge O; Tanaka A; Morio M
    In Vivo; 1992; 6(5):503-5. PubMed ID: 1457743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of halothane anesthesia and trifluoroacetic acid on protein binding of benzodiazepines.
    Suárez E; Aguilera L; Calvo R; Rodríguez-Sasiaín JM; Martínez-Jorda R
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):693-6. PubMed ID: 1770832
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening for antibodies associated with halothane hepatitis.
    Hastings KL; Thomas C; Hubbard AK; Gandolfi AJ
    Br J Anaesth; 1991 Dec; 67(6):722-8. PubMed ID: 1768541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunological studies on the mechanism of halothane-induced hepatotoxicity: immunohistochemical evidence of trifluoroacetylated hepatocytes.
    Satoh H; Fukuda Y; Anderson DK; Ferrans VJ; Gillette JR; Pohl LR
    J Pharmacol Exp Ther; 1985 Jun; 233(3):857-62. PubMed ID: 3891968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biotransformation of halothane in guinea pig liver slices.
    Ghantous HN; Fernando J; Gandolfi AJ; Brendel K
    Drug Metab Dispos; 1990; 18(4):514-8. PubMed ID: 1976077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Absorption, biotransformation, and storage of halothane.
    Holaday DA
    Environ Health Perspect; 1977 Dec; 21():165-9. PubMed ID: 348455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Experimental immunity to a metabolite of halothane and fluroxene: cutaneous delayed-type hypersensitivity.
    Mathieu A; DiPadua D; Mills J; Kahan B
    Anesthesiology; 1974 Apr; 40(4):385-90. PubMed ID: 4150486
    [No Abstract]   [Full Text] [Related]  

  • 57. Macrophage migration inhibitory factor in drug-induced liver injury: a role in susceptibility and stress responsiveness.
    Bourdi M; Reilly TP; Elkahloun AG; George JW; Pohl LR
    Biochem Biophys Res Commun; 2002 Jun; 294(2):225-30. PubMed ID: 12051698
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the requirements for hepatic injury with halothane and enflurane in rats.
    Lind RC; Gandolfi AJ; Sipes IG; Brown BR
    Anesth Analg; 1985 Oct; 64(10):955-63. PubMed ID: 4037395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Halothane metabolism. Impairment of hepatic omega-oxidation of leukotrienes in vivo and in vitro.
    Huwyler J; Jedlitschky G; Keppler D; Gut J
    Eur J Biochem; 1992 Jun; 206(3):869-79. PubMed ID: 1318837
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane.
    Kenna JG; Satoh H; Christ DD; Pohl LR
    J Pharmacol Exp Ther; 1988 Jun; 245(3):1103-9. PubMed ID: 3385639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.